8-K: Darling Ingredients Forms Collagen JV with Tessenderlo
Joint Venture Announcement
Darling Ingredients and Tessenderlo Group have signed a definitive agreement to combine their collagen and gelatin businesses into a new joint venture, NewCo Collagen LLC, with Darling holding an 85% stake.
Summary
- Darling Ingredients Inc. and Tessenderlo Group NV have entered into a definitive agreement to form a joint venture, NewCo Collagen LLC.
- The joint venture will combine Darling Ingredients' Rousselot collagen and gelatin business with Tessenderlo Group's PB Leiner business.
- Darling Ingredients will hold an 85% equity interest in NewCo, and Tessenderlo Group will hold the remaining 15%.
- The new company is expected to have initial annual revenue of approximately $1.5 billion and a total gelatin and collagen capacity of about 200,000 metric tons across 22 facilities globally.
- The transaction requires no cash or initial investment from either party.
- The completion of the transaction is subject to regulatory approvals and other closing conditions, with an expected close in 2026.
- Tessenderlo Group will have a right to require Darling Ingredients to purchase its equity in NewCo at a pre-agreed price on the five or seven-year anniversaries of the closing.
Sentiment
Score: 8
Explanation: The filing announces a strategic joint venture that significantly expands Darling Ingredients' presence in a high-growth market without requiring initial cash investment. Management commentary is highly positive, emphasizing growth, synergies, and shareholder value. The only minor negative is the future put option, but overall, the news is very favorable for the company's strategic direction and market position.
Positives
- Creates a top-tier, collagen-based health, wellness, and nutrition products company.
- Positions the new company to capitalize on global collagen growth, which is described as the fastest-growing part of Darling's food segment.
- Expected to generate significant opportunities for synergies and the development of the Nextida portfolio of products, designed to deliver targeted health benefits and increase earnings.
- Expands options to enhance shareholder value for Darling Ingredients.
- No cash or initial investment required from either party for the formation of the joint venture.
Negatives
- Tessenderlo Group holds a put option, allowing them to require Darling Ingredients to purchase their 15% equity stake at a pre-agreed price on the five or seven-year anniversaries of closing, which could represent a future financial obligation for Darling.
Risks
- The completion of the transaction is subject to all required regulatory approvals and certain other closing conditions, which may not be met.
- There is no assurance that Darling Ingredients will realize the anticipated benefits of the proposed transaction.
- Numerous factors, many beyond Darling's control, could cause actual results to differ materially from forward-looking statements.
- General risks discussed in Darling's filings with the Securities and Exchange Commission.
Future Outlook
The strategic partnership is expected to create new opportunities for growth, enhance shareholder value, and accelerate innovation and scale in the dynamic collagen market. The integration of the two companies is anticipated to provide significant opportunities to realize synergies and develop the Nextida portfolio of products, which are designed to deliver targeted health benefits and increase earnings.
Management Comments
- "This strategic partnership is expected to create new opportunities for growth, while expanding options to enhance shareholder value for Darling Ingredients." Randall C. Stuewe, Chairman and CEO of Darling Ingredients.
- "Collagen continues to be the fastest-growing part of our food segment, and with PB Leiners talented team, assets and product portfolio, we are well positioned to accelerate innovation, scale and growth in this dynamic market." Randall C. Stuewe, Chairman and CEO of Darling Ingredients.
- "This final agreement is an important step forward in building a stronger future for our partnership." Luc Tack, Chief Executive Officer, Tessenderlo Group.
Industry Context
The announcement positions Darling Ingredients to further capitalize on the rapidly expanding global collagen market, which is identified as the fastest-growing segment within its food division. By combining its Rousselot brand with Tessenderlo Group's PB Leiner, the joint venture aims to create a leading player in the health, wellness, and nutrition sector, leveraging increased scale and a broader product portfolio to drive innovation and meet growing consumer demand for collagen-based products.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Expected to benefit from new growth opportunities and enhanced shareholder value.
- Employees: Integration of two companies implies potential changes or new opportunities for employees of Rousselot and PB Leiner.
- Customers: Potential for expanded product portfolio (Nextida) and accelerated innovation in collagen-based products.
- Suppliers: Potential for changes in supply chain dynamics due to combined operations.
Next Steps
- Obtain all required regulatory approvals.
- Satisfy certain other closing conditions.
- Enter into an amended and restated limited liability company agreement for NewCo.
- Close the transaction, expected in 2026.
- Integrate the two companies to realize synergies and develop the Nextida portfolio of products.
Key Dates
| Date | Description |
|---|---|
| 2025-12-10 | Date of report and press release announcing entry into definitive agreement for joint venture. |
| 2026 | Expected closing year for the transaction, pending regulatory approvals. |
| 5 or 7 years after closing | Anniversaries when Tessenderlo Group has the right to require Darling Ingredients to purchase its equity in NewCo. |
Recommendation
strong buyThe definitive agreement to form a joint venture in the high-growth collagen market, with Darling Ingredients holding an 85% majority stake and requiring no initial cash investment, is a highly strategic and financially sound move. The combined entity's significant revenue and capacity, coupled with anticipated synergies and management's strong positive outlook, position Darling Ingredients for accelerated growth and enhanced shareholder value. The only minor future obligation is Tessenderlo's put option, which is a known and pre-agreed term. This development significantly strengthens Darling's market leadership in a key segment.
Keywords
Darling Ingredients, Tessenderlo Group, Joint Venture, Collagen, Gelatin, Rousselot, PB Leiner, Health and Wellness, Nutrition, Food Ingredients, Strategic Partnership, NewCo Collagen LLC, DAR, TESB
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.